Esophagectomy

• 

  Subject Areas on Research

  • "Early" thoracic duct ligation for chylothorax after esophagectomy means "now". 
  • A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett's oesophagus. 
  • A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia. 
  • A guide for surveillance of patients with Barrett's esophagus. 
  • A unique tripartite collision tumor of the esophagus: A case report. 
  • Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma. 
  • An Odyssey of complications from band, to sleeve, to bypass; definitive laparoscopic completion gastrectomy with distal esophagectomy and esophagojejunostomy for persistent leak. 
  • An e-score is born. 
  • Analysis of recurrence and survival after hypopharyngeal ablative surgery with radial forearm free flap reconstruction. 
  • Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. 
  • Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer. 
  • Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis. 
  • Comparison Between the 2007 and 2014 American College of Cardiology/American Heart Association Guidelines on Perioperative Evaluation for Noncardiac Surgery. 
  • Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. 
  • Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinoma. 
  • Esophageal Cancer Clinical Practice Guidelines. 
  • Esophageal cancer. 
  • Esophagectomy outcomes at low-volume hospitals: the association between systems characteristics and mortality. 
  • Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. 
  • Gastric tube volvulus following an Ivor-Lewis esophagectomy. 
  • Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer. 
  • Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions. 
  • Improving outcomes after esophagectomy: the importance of preventing postoperative pneumonia. 
  • Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer. 
  • Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. 
  • Laparoscopic myotomy for achalasia: predictors of successful outcome after 200 cases. 
  • Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. 
  • Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical Outcomes From The Society of Thoracic Surgeons National Database. 
  • Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis. 
  • New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma. 
  • Outcomes after esophagectomy: a ten-year prospective cohort. 
  • Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer. 
  • Patterns of recurrence after trimodality therapy for esophageal cancer. 
  • Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. 
  • Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. 
  • Predictors of Major Morbidity or Mortality After Resection for Esophageal Cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database Risk Adjustment Model. 
  • Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. 
  • Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model. 
  • Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered? 
  • Prevalence and resource utilization for vocal fold paralysis/paresis after esophagectomy. 
  • Primary malignant melanoma of the esophagus. 
  • Reducing hospital morbidity and mortality following esophagectomy. 
  • Respiratory complications after esophagectomy. 
  • Short-term outcomes after esophagectomy at 164 American College of Surgeons National Surgical Quality Improvement Program hospitals: effect of operative approach and hospital-level variation. 
  • Socioeconomic Status, Not Race, Is Associated With Reduced Survival in Esophagectomy Patients. 
  • Specificity of procedure volume and in-hospital mortality association. 
  • Staging of esophageal cancer by EUS: staging accuracy revisited. 
  • Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing? 
  • The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy. 
  • The Society of Thoracic Surgeons Composite Score for Evaluating Esophagectomy for Esophageal Cancer. 
  • The contemporary role of minimally invasive esophagectomy in esophageal cancer. 
  • The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus. 
  • The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature. 
  • Thoracoscopic versus robotic approaches: advantages and disadvantages. 
  • Transhiatal esophagogastrectomy for an isolated ovarian cancer metastasis to the esophagus. 
  • Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. 
  • Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer. 
  • Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection. 
  • Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. 
  • Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. 
  • Venous Thromboembolism Prophylaxis For Esophagectomy: A Survey of Practice Patterns Among Thoracic Surgeons. 
• 

  Keywords of People

  • Esclamado, Ramon Mitra, Richard Hall Chaney, Sr. Professor of Otolaryngology, Surgery, Head and Neck Surgery and Communication Sciences
  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology
  • Uronis, Hope Elizabeth, Associate Professor of Medicine, Medicine, Medical Oncology